MECHANISMS MEDIATING N-G-NITRO-L-ARGININE METHYL ESTER-INDUCED HYPOPHAGIA IN MICE

N-G-Nitro-L-arginine methyl ester (50 mg/kg s.c.), an inhibitor of nit ric oxide (NO) synthase, has been reported to increase brain serotonin (5-hydroxytryptamine, 5-HT) metabolism and induce hypophagia. Convers ely, enhanced NO synthase activity is found to be accompanied by a dec rease in 5-HT level. This negative correlation between NO and 5-HT in the regulation of food intake was further studied in mice. 5-HT deplet ion by p-chlorophenylalanine (250 mg/kg i.p., twice daily for 2 days) failed to antagonize the hypophagic effect of N-G-nitro-L-arginine met hyl ester. Similarly, treatment with the NO synthesis precursor, L-arg inine (1000 mg/kg s.c.), did not reverse the anorexia induced by fenfl uramine (10 mg/kg s.c.), a 5-HT releaser/uptake inhibitor. Pretreatmen t with (-)-pindolol, methysergide and ritanserin had no effect on the hypophagic action of N-G-nitro-L-arginine methyl ester, suggesting the lack of involvement of 5-HT1 and 5-HT2 receptors. The selective neuro nal NO synthase inhibitor, 7-nitroindazole (12.5-50.0 mg/kg i.p.), how ever, did not exhibit any hypophagic effect whilst N-G-nitro-L-arginin e methyl ester increased gastric retention, which may subsequently ind uce satiety. Moreover, the hypophagic effect of N-G-nitro-L-arginine m ethyl ester, which was unassociated with changes in water intake and m alaise induction, was also unattenuated by cholecystokinin (CCK) recep tor antagonists, devazepide (10 mg/kg i.p.) and PD 135,158 ([1S-[1 alp ha,2 beta[S (S*)],4 l)oxyl]carbonyl]amino]propyl]amino]-1-phenylethyl ] amino]-4-oxo-butanoic acid N-methyl-D-glucamine salt; 1 mg/kg i.p.). Furthermore, a decrease in exploratory activity and diminished prefer ence for favorable sensory cues were observed in N-G-nitro-L-arginine methyl ester-treated animals. These results suggest that mechanisms ot her than 5-HT are possibly involved in mediating the hypophagic effect of N-G-nitro-L-arginine methyl ester treatment in mice.